Studies have shown that nearly 60% of breast cancer cases in India are diagnosed at Stage III or IV, with the 5-year survival ...

A private, clinical-stage biopharma company developing small-molecule–based therapies administered directly to treat ...

The FDA has approved Osvyrti (denosumab-desu), a biosimilar to Prolia (denosumab), and Jubereq (denosumab-desu), a biosimilar to Xgeva (denosumab).

One thing Marcus Semien can clearly still provide the Mets, even at age 35, is standout defense. Semien, whom the Mets ...

RSNA attendees can find Profound at Booth #3153, South Hall A, for demonstrations of the newly launched TULSA-AI Volume Reduction module, along with case studies and feature upgrades from the pilot ...

Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to ...

Pune: New global evidence now identifies air pollution as the second leading cause of lung cancer, prompting doctors to urge ...

It was a joyful Christmas in Kentucky in 2023, and life finally seemed to be smiling on Leydis Fernandez. At 30, she had ...

Zetagen Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company pioneering first-of-its-kind, intratumoral treatments for metastatic and primary breast cancer, today announced ...

The former two-division UFC champion, Jon “Bones” Jones, has been making the most of his time in the Chechen Republic.

Australia’s Therapeutic Goods Administration (TGA) has issued a safety warning regarding the discontinuation of Prolia ...

Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to its high mortality. This ...